To investigate the role of leptin during pregnancy, we assessed leptin production by pure cultured human cytotrophoblastic cells (CTB), its regulation by cytokines and 17β-oestradiol and its effects on human chorionic gonadotrophin (HCG) secretion. Purified CTB from first trimester placenta were incubated in duplicates in the presence or absence of cytokines or 17β-oestradiol. Medium was harvested on day 2 and the culture stopped on day 4. Results were corrected for protein content of each individual well and expressed as percent of controls per day (mean ⍨ SEM). Basal CTB leptin production was 25.2 ⍨ 2.6 (ng/mg prot). In comparison with controls, leptin production was stimulated to 320 ⍨ 16% (P < 0.0001) and 195 ⍨ 3.2% (P < 0.0004) by 3 and 10 ng/ml of interleukin-1α respectively. 17β-oestradiol 10 -6 to 10 -9 mol/l increased basal leptin production 5-9-fold, while 10 -5 mol/l had no such effect. Basal CTB HCG secretion was 5722 ⍨ 1055 (mIU/mg prot). There was a dose-dependent leptin-induced increase in HCG secretion (P ⍧ 0.0039) reaching a 5-fold increase with a leptin concentration of 1 µg/ml (P < 0.006). Gonadotrophin-releasing hormone (GnRH) 8.5⍥10 -8 mol/l significantly increased HCG secretion to 140 ⍨ 21% of controls (P ⍧ 0.031). Cetrorelix (0.1 µg/ml) inhibited leptin-induced HCG secretion (P ⍧ 0.0028).
Introduction
, macrophage-colony stimulating factor The obese gene product, leptin, a 167 amino acid peptide (M-CSF) (Jokhi et al., 1995; Omigbodum et al., 1998 ) and identified in 1994 (Zhang et al., 1994 , has provided a potential 17β-oestradiol (Petraglia et al., 1995; Licinio et al., 1998) , all link between food intake, energy balance and reproductive well-recognized paracrine/autocrine and endocrine modulators events (Chehab et al., 1996) . A well-recognized site of leptin of placental functions. production is the adipocyte. Thus, the amount of body fat Structural prediction indicates that leptin might fold into a appears as the strongest determinant of plasma leptin concytokine-like structure (Madej et al., 1995) . As the leptin centrations, and factors such as food intake, insulin concentrareceptor belongs to the class I cytokine receptor superfamily tions, glucocorticoids and catecholamines may influence leptin (Tartaglia et al., 1997) , it is possible that leptin may act as a gene expression (Bray and York, 1997) .
paracrine/autocrine regulator of placental function. As cytoRecently, it has been demonstrated that circulating leptin kines are involved in placental endocrine functions (Masuhiro concentrations were elevated during pregnancy, reaching a et Li et al., 1992; Yanushpolski et al., 1993) , the peak during the second trimester (Hardie et al., 1997 ; Schubring present work was also undertaken to elucidate such a role for et al., 1997) . However, fat deposition during pregnancy or leptin. Using pure first trimester human CTB in culture, pregnancy-induced endocrine changes could hardly explain the secretion of human chorionic gonadotrophin (HCG) was such dramatic changes implying that the feto-placental unit assessed in vitro by CTB and the influence of recombinant could be another important source of leptin (Matsuzaki et al., human leptin (rhLeptin) on CTB HCG production was 1997; Senaris et al., 1997) . The present work was undertaken evaluated. to elucidate the potential contribution of first trimester placenta to circulating leptin concentrations during pregnancy and to assess its regulation by factors of trophoblastic and/or Materials and methods endometrial origin. Using pure first trimester human cytotrophoblastic cells (CTB) in culture, CTB leptin production was CTB were isolated and purified in accordance with a previously measured in vitro either under basal conditions or stimulated by described method (Bischof et al., 1995) . Briefly, pregnancy trophoblastic tissue was obtained from legal abortions at 6-12 weeks from interleukin-1α (IL-1α), tumour necrosis factor-α (TNFα) (Li the last menstrual period, digested with trypsin, separated from blood cells and syncytia on a discontinuous Percoll gradient and immunopurified by antibody-coated magnetic particles (anti-CD45) (Dyna Beads, Milan, Geneva) in order to eliminate all contaminating leukocytes as previously reported (Bischof et al., 1995) . CTB viability was assessed by Trypan Blue (Sigma, Buchs, Switzerland) exclusion and cells diluted to 10 6 cells/ml. IL-1β, IL-6, TNFα and M-CSF were purchased from R&D Systems (Bühlmann Laboratories, Basle, Switzerland) and oestradiol from Sigma. RhLeptin was puchased from R&D Systems, gonadotrophin-releasing hormone (GnRH) from Dr J.Rivier (The Salk Institute, La Jolla, CA, USA), and Cetrorelix from Organon, Saffikon, Switzerland.
Culture conditions CTB (100 µl, 106 cells/ml, Ͼ90% viability by Trypan Blue exclusion) were incubated in duplicates in the presence or absence of IL-1α (0.01-10 ng/ml), TNFα (1-100 ng/ml), M-CSF (0.1-100 ng/ml) Figure 1 . Effect of interleukin-1 (IL-1β) on cytotrophoblastic cell (Simòn et al., 1994) or oestradiol (10 -9 to 10 -5 mol/l) (Petraglia (CTB) leptin secretion (n ϭ 6 from three different CTB preparations). Values are expressed as means Ϯ SEM. Licinio et al., 1998) , rhLeptin (1-1000 ng/ml), GnRH (8.5ϫ10 -10 to 8.5ϫ10 -8 mol/l) (Bramley et al., 1992) , Cetrorelix (0.1-5 µg/ml) or rhLeptin (2 µg/ml) with or without Cetrorelix (0.1 µg/ml). Concentrations of Cetrorelix and rhLeptin were chosen arbitrarily. Incubation was performed in 12-well tissue culture plate (Costar, Cambridge, MA, USA) under a 5% CO 2 and 95% air atmosphere in a humid incubator at 37°C. Culture medium was Dulbecco's modified Eagle's medium (DMEM; Gibco, Basel, Switzerland) containing 2 mmol/l L-glutamine, 4.2 mmol/l magnesium sulphate, 25 mmol/l HEPES, 1% gentamycin, 1% amphotericin B, 100 µg/ml streptomycin and 100 IU/ml penicillin in the absence of serum. Medium was harvested on day 2 and 4 and the culture stopped on day 4. The supernatants were divided into aliquots and stored at -20°C until assayed. The cells were lysed with 200 µl Triton X-100 (2.5% in water) and stored at -20°C for total cell protein measurements. Duplicate wells were run for each treatment condition and the experiments repeated three times with different CTB preparations. Values are expressed as means Ϯ SEM. immunosorbent assay (ELISA) (DRG diagnostics, Cis-Medipro, Vernier, Switzerland) with a sensitivity of 0.2 ng/ml and intra-and daily basal leptin secretion over the 4-day period. Figure 1 inter-assay coefficients of variation of 4.3 and 8.6% respectively. The leptin assay neither cross-reacts with mouse, rat leptin nor with illustrates IL-1β-induced leptin production by CTB. When human proteins such as proinsulin, C-peptide, glucagon or insulincompared with controls, leptin production was 320 Ϯ 16% like growth factor I. HCG was measured in the supernatants by a (P Ͻ 0.0001) and 195 Ϯ 3.2% (P ϭ 0.0004) after incubation microparticle immunoassay (MEIA) (IMX, Abbot USA) with a with 3 and 10 ng/ml of IL-1β respectively. Lower concentrasensitivity of 0.1 mIU and intra-and inter-assay coefficients of tions of this cytokine were without effect. In contrast to IL-1β, variation of Ͻ4%. Total cell proteins were measured in the cell lysate 1-100 ng/ml of TNFα or 0.1-100 ng/ml of M-CSF had no by the Bio-Rad protein assay using bovine serum albumin as the significant effect on CTB leptin production (results not shown).
standard (Bio-Rad, München, Germany).
Effects of oestradiol

Statistical analysis
Results were corrected for protein content of each individual well Figure 2 demonstrates the effects of oestradiol on CTB leptin and expressed as percentage of their respective controls per day (CTB production. Oestradiol 10 -9 to 10 -6 mol/l did stimulate CTB in the absence of cytokines or oestradiol or rhLeptin, mean Ϯ SEM) leptin production while 10 -5 mol/l did not.
or as values per mg/cell protein per day (mean Ϯ SEM). Statistical analysis were performed by analysis of variance using Fisher's test
Effects of recombinant human leptin
on the Statview 4.5 program on a Power Macintosh 7100/66 computer.
Mean CTB HCG production under basal conditions was
The different values were compared among them and to the controls. 5722 Ϯ 1055 mIU/mg prot. There was no significant change of daily basal HCG secretion over a 4-and even an 8-day
Results
period of CTB culture (results not shown). RhLeptin stimulated Effects of cytokines
HCG production by CTB in a concentration-dependent manner (P ϭ 0.0039), as illustrated in Figure 3 . When compared with Mean CTB leptin production under basal conditions was 25.2 Ϯ 2.6 (ng/mg prot). There was no significant change of controls, HCG production was 527 Ϯ 159% (P Ͻ 0.006) after preparations may explain such a result. The addition of Cetrorelix at a concentration of 0.1 µg/ml together with rhLeptin inhibited leptin-induced HCG secretion which was then 119.5 Ϯ 6.4% (P ϭ 0.0028).
Discussion
Circulating peripheral leptin concentrations are elevated during pregnancy (Hardie et al., 1997; Schubring et al., 1997) and the placenta has been suggested to contribute to this pregnancyrelated increase. Several recent reports have demonstrated leptin gene expression by human placental tissue or the placenta-derived cell line BeWo (Matsuzaki et al., 1997; Senaris et al., 1997) . However, those only provide indirect of human cytotrophoblast.
Little is known about the regulation of leptin secretion in the placenta. Placental age may be important as placental incubation with 1000 ng/ml of rhLeptin. There was no observed syncytium formation when stained with desmoplakin (results leptin gene expression is higher in the first trimester villi when compared with third trimester villi (Matsuzaki et al., 1997) . not shown).
This fits rather well with longitudinal measurements of periEffects of GnRH and GnRH antagonists pheral concentrations of leptin during pregnancy which are highest in the second trimester (Hardie et al., 1997) . Recently, Figure 4 displays the effects of GnRH on HCG secretion by CTB. GnRH 8.5ϫ10 -8 mol/l increased HCG secretion which insulin has been suggested as another important regulator of placental leptin secretion (Lepercq et al., 1998) . Another was 140 Ϯ 21% of controls (P ϭ 0.031). Cetrorelix did not modify basal HCG secretion.
important modulator of leptin secretion in the placenta is cell differentiation. Immunohistochemical studies have demonEffects of GnRH antagonists on leptin-induced HCG strated a more intense staining for leptin in syncytiotrophoblast secretion in comparison with cytotrophoblast (Matsuzaki et al., 1997; Senaris et al., 1997) . Moreover, forskolin-induced syncytium Figure 5 illustrates the effects of Cetrorelix on CTB HCG secretion induced by rhLeptin (2 µg/ml). In that set of formation in BeWo cells was shown to increase leptin secretion (Matsuzaki et al., 1997) . In this study, basal leptin secretion experiments, rhLeptin raised HCG secretion to 160.2 Ϯ 13.3% of controls. Leptin-induced HCG secretion was not as high remains constant over a 4-day period. This was observed in the absence of serum, a known promoter of syncytium formation. with 2 µg/ml rhLeptin when compared with a 1 µg/ml concentration. However, we know that variability from one cell Staining of CTB with desmoplakin after incubation with leptin did not demonstrate syncytium formation (results not preparation to the other and different gestational ages between shown). Taken together, this makes syncytium formation an mechanism for the decrease in leptin secretion at 10 µmol/l of oestradiol may be down-regulation of the oestradiol receptor unlikely hypothesis to explain the results of this study. However, M-CSF has been shown to induce differentiation of as it occurs in other reproductive tissues (Medlock et al., 1991; Simerly et al., 1991; Simòn et al., 1994) and with glucocorticoid cytotrophoblast (Saito et al., 1993) . No such results appear to be available for IL-1. This would warrant further investigation. and thyroid hormone receptors (Raaka et al., 1981; Rosewicz et al., 1988) . The results of this study indicate that IL-1β is a regulator of leptin secretion in first trimester CTB. Its effect seems to No clear role for placental leptin secretion has been demonstrated. So far, cord blood concentrations have been found to be specific, as neither TNFα nor M-CSF changed leptin secretion. IL-1β is known to stimulate in-vivo leptin secretion be correlated with birth weight and placenta weight (Harigaya et al., 1997; Hassink et al., 1997; ; in humans (Janik et al., 1997) but it remains unclear whether this is a direct action of IL-1β on the adipocyte or via an Matsuda et al., 1997; Schubring et al., 1997; Helland et al., 1998; Machini et al., 1998; Tamura et al., 1998) , implying endocrine cascade involving corticosteroids. In this study, we provide evidence of a direct effect of IL-1β on CTB leptin that the feto-placental leptin production may be involved in placental and fetal growth regulation. One putative role for secretion. The cellular mechanism of such an effect remains unclear. However, IL-1 receptors are present on the trophoblast leptin could be related to follicular growth, egg and embryo polarity (Antczak and van Blerkom 1997; Cioffi et al., 1997; (Simòn et al., 1994) . A placenta-specific enhancer element (placental leptin enhancer, or PLE) has recently been identified Edwards and Beard, 1997; Antczak et al., 1998) . This study provides the first direct evidence for a definite role of leptin in the promoter region of the leptin gene (Bi et al., 1997) , with at least three protein binding sites. Protein binding to the in a fundamental placental function, i.e. HCG production. During pregnancy, trophoblast differentiates in a multistep PLE3 motif up-regulates the transcription of the leptin gene in the human placenta. Since IL-1 exerts similar effects and process that converts cytotrophoblast to syncytiotrophoblast (Ringler et al., 1990) . As the placenta grows and matures, since, in other cell systems, IL-1 effects are mediated through the NF-κB transcription factor (Friedman et al., 1996; Bird there is increased formation of syncytiotrophoblast with an associated secretion of HCG. In models of trophoblast et al., 1997; Reddy et al., 1997) , it is tempting to speculate that IL-1β may induce leptin expression through an NF-κB-differentiation in vitro, the onset of HCG production appears to parallel the formation of syncytiotrophoblast (Kliman et al., dependent activation of PLE3. The specificity of IL-1β is interesting because the complete IL-1 system is present at the 1986). In this study, basal HCG secretion remained constant over time. This was observed in the absence of serum, a feto-maternal interface and is clearly involved in implantation and placentation (Simòn et al., 1994) . This raises the important known promoter of syncytium formation and, indeed, cultured CTB showed no syncytium formation. question as to whether leptin is also involved in these crucial events.
Trophoblast secretion of HCG is regulated by a multitude of endocrine and paracrine/autocrine factors. GnRH (Siler-Khodr Oestradiol plays a role in the regulation of fetal growth (Abdul-Karim et al., 1991) , onset of parturition (Chibbar et al., et al., 1986) , epidermal growth factor (EGF) (Morrish et al., 1987) , IL-1 and IL-6 , leukaemia 1995), placental steroidogenesis (Petraglia et al., 1995 , Grimes et al., 1996 Babishkin et al., 1997) , release of neuropetides inhibitory factor (Sawai et al., 1995) , TNF , activin (Petraglia et al., 1989) and M-CSF (Saito et al., (Petraglia et al., 1990) , release of glycoproteins (Wilson et al., 1984; Petraglia et al., 1995) and leptin secretion (Sivan 1991) are recognized as promoters of HCG secretion while progesterone (Szilàgyi et al., 1993) , inhibin (Petraglia et al., et al., 1998) . Administration of oestradiol antagonist reverses oestradiol placental actions, pointing towards a receptor-1989), transforming growth factor , GnRH antagonist (Siler-Khodr et al., 1983) and RU 486 (Das mediated effect. However, the exact mechanisms of oestradiol action within the placenta are still a matter of debate. Classical et al., 1987; Szilàgyi et al., 1993) are inhibitors of HCG secretion. However, fine tuning of HCG secretion during cytosol oestradiol receptors seem to be absent or in an extremely low number, thus escaping classical immunological pregnancy is still incompletely understood and the dynamic pattern of HCG may involve an up-and down-regulation of and molecular detection (Rossmanith et al., 1997) . This raises the possibility that oestradiol actions within the placenta are the GnRH receptor (Lin et al., 1995) . The results of this study confirm the role of GnRH in HCG mediated by a non-classical membrane-bound receptor. This study demonstrated a concentration-dependant bimodal pattern secretion with a maximal stimulatory effect at 8.5ϫ10 -8 mol/l.
The need for such a high concentration of GnRH probably of oestradiol on the regulation of leptin secretion. There was an increase in leptin secretion of up to 100 nmol/l of oestradiol, reflects the presence of low affinity GnRH receptors within the placenta (Bramley et al., 1992) . Changes in intracellular which is close to its physiological concentration during late pregnancy (30-50 nmol/l) (Tulchinski et al., 1972) . This phosphoinositol turnover have been proposed (Conn et al., 1986) as a possible mechanism of GnRH effect. Likewise, corroborates in-vivo studies where leptin concentrations were correlated with oestradiol concentrations during pregnancy, GnRH action within the placenta may involve Ca 2ϩ ions, similar to the situation described in the pituitary (Mathialagan especially during the first trimester (Hardie et al., 1997) . However, higher doses of oestradiol did not affect basal leptin et al., 1989) . A high dose of GnRH may quickly desensitize the local receptors at the post-receptor level. Alternatively, values. Neither the underlying molecular mechanisms, nor the biological or pharmacological significance of this biphasic high concentrations of GnRH have been demonstrated to down-regulate GnRH receptor without altering its receptor pattern of oestradiol response are known. One possible beta2 sequestration in a subpopulation of human ovarian follicle cells. mRNA content (Tstsumi et al., 1990) but with diminished Hum. Reprod., 12, 2226 -2234 polysome formation (Tsutsumi et al., 1993) to be mediated by nitric oxide (Yu et al., 1997) . However, the
